Trial intelligence / Profile preview

Bioequivalence of NAC Uncoated vs Film-coated Tablets

NCT02265224Phase 1Completed

Sponsor
Zambon
Start
Sep 2014
Primary completion
Sep 2014
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of acetylcysteine in mucus hypersecretion (2 arms), sponsored by Zambon. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time 0 to last measurable concentration. Started Sep 2014; status: completed.

02

Drugs

acetylcysteine
03

Conditions

mucus hypersecretion

Beyond the preview

Go deeper on NCT02265224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02265224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call